These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35408534)

  • 1. Research Progress of Natural Small-Molecule Compounds Related to Tumor Differentiation.
    He X; Liao Y; Liu J; Sun S
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell differentiation and malignancy.
    Sachs L
    Cell Biophys; 1986 Dec; 9(1-2):225-42. PubMed ID: 2436796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of small molecule compounds inducing differentiation of stem cells].
    Li X; Shan L; Li WL; Zhang SD; Zhang WD
    Yao Xue Xue Bao; 2011 Feb; 46(2):121-6. PubMed ID: 21542280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural compounds and pharmaceuticals reprogram leukemia cell differentiation pathways.
    Morceau F; Chateauvieux S; Orsini M; Trécul A; Dicato M; Diederich M
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):785-97. PubMed ID: 25886879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis.
    Rohner A; Langenkamp U; Siegler U; Kalberer CP; Wodnar-Filipowicz A
    Leuk Res; 2007 Oct; 31(10):1393-402. PubMed ID: 17391757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor genes in myeloid differentiation and leukemogenesis.
    Britschgi C; Fey MF
    Future Oncol; 2009 Mar; 5(2):245-57. PubMed ID: 19284382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Securinine, a myeloid differentiation agent with therapeutic potential for AML.
    Gupta K; Chakrabarti A; Rana S; Ramdeo R; Roth BL; Agarwal ML; Tse W; Agarwal MK; Wald DN
    PLoS One; 2011; 6(6):e21203. PubMed ID: 21731671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundamentals of chemo-differentiation therapy of myeloid leukemia.
    Hozumi M
    Anticancer Res; 1994; 14(3A):1177-92. PubMed ID: 8074470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of Cancer Stem Cells by Using Synthetic Small Molecules: Toward New Therapeutic Strategies against Therapy Resistance.
    Maucort C; Di Giorgio A; Azoulay S; Duca M
    ChemMedChem; 2021 Jan; 16(1):14-29. PubMed ID: 32803855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for induction of differentiation and toxicity to blast cells by chemotherapeutic compounds in human myeloid leukemia.
    Lotem J; Berrebi A; Sachs L
    Leuk Res; 1985; 9(2):249-58. PubMed ID: 3857410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
    Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
    Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
    Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Receptors as Potential Therapeutic Targets for Myeloid Leukemia.
    Pan P; Chen X
    Cells; 2020 Aug; 9(9):. PubMed ID: 32824945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of TCTP for Cellular Differentiation and Cancer Therapy.
    Seo EJ; Fischer N; Efferth T
    Results Probl Cell Differ; 2017; 64():263-281. PubMed ID: 29149414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells.
    Funato K; Miyazawa K; Yaguchi M; Gotoh A; Ohyashiki K
    Leukemia; 2002 Aug; 16(8):1519-27. PubMed ID: 12145693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of differentiation of fresh myelogenous leukemic cells by compounds that induce a human promyelocytic leukemic line (HL-60) to differentiate.
    Koeffler HP; Yelton L; Prokocimer M; Hirji K
    Leuk Res; 1985; 9(1):73-81. PubMed ID: 3857407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methyltransferases as targets for cancer therapy.
    Ghoshal K; Bai S
    Drugs Today (Barc); 2007 Jun; 43(6):395-422. PubMed ID: 17612710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy.
    Hughes PJ; Marcinkowska E; Gocek E; Studzinski GP; Brown G
    Leuk Res; 2010 May; 34(5):553-65. PubMed ID: 19811822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo control of differentiation of myeloid leukemic cells by recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3.
    Lotem J; Sachs L
    Blood; 1988 Feb; 71(2):375-82. PubMed ID: 2447982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.